Overdose Safety Planning

Current Status
Not Enrolled
Price
Free
Get Started

This is a recorded session from our partner Zero Overdose.

Duration: 1 hour

Overview:

Enhance your competency in screening and addressing the risk of overdose through the implementation of the Overdose Safety Planning Intervention. Gain proficiency in safety planning for overdose risk, understand substance use and addictive disorders, and discover how you can actively contribute to preventing overdose events.

Learning Objectives:

  • Participants will understand and define overdose safety plans and their importance in prevention. 
  • Identify people at risk of drug overdoses through key risk factors. 
  • Participants will create and implement personalized overdose safety plans.

Speaker: Dr. Julian Mitton

Dr. Julian Mitton is a healthcare innovation leader and public health champion committed to advocating for the improved and equitable care of traditionally underserved populations. With a diverse clinical background in population health and behavioral health, and advanced training in health services research and implementation science, he has been able to leverage research, leadership, strategic partnerships and health policy to advocate for underserved communities through clinical innovations and policy change.
Dr. Mitton has collaborated with several leading healthcare organizations, including Harvard Medical School, CommonSpirit Health, Concert Health and Redesign Health. He is a general internist and addiction medicine physician and now serves as Medical Director at Zero Overdose. He completed medical school at SUNY Stony Brook and his residency at Massachusetts General Hospital. Dr. Mitton also received an MPH from the Harvard School of Public Health and completed a postdoctoral fellowship in implementation science at Harvard Medical School. He is a published author and researcher, with work appearing in such reputable journals as NEJM Catalyst and the Journal of Addiction Medicine. Dr. Mitton’s recent efforts have focused on tech-enabled population health and clinical innovations, including integrated behavioral health and programs to promote access to evidence-based medications for addiction treatment (MAT).